A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction
Open accessThe DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Abstract
It has been long known that patients treated with ionizing radiation carry a risk of developing a second cancer in their lifetimes. Factors contributing to the recently renewed concern about the second cancer include improved cancer survival rate, younger patient population as well as emerging treatment modalities such as intensity-modulated radiation treatment (IMRT) and proton therapy that can potentially elevate secondary exposures to healthy tissues distant from the target volume. In the past 30 years, external-beam treatment technologies have evolved significantly, and a large amount of data exist but appear to be difficult to comprehend and compare. This review article aims to provide readers with an understanding of the principles and methods related to scattered doses in radiation therapy by summarizing a large collection of dosimetry and clinical studies. Basic concepts and terminology are introduced at the beginning. That is followed by a comprehensive review of dosimetry studies for external-beam treatment modalities including classical radiation therapy, 3D-conformal x-ray therapy, intensity-modulated x-ray therapy (IMRT and tomotherapy) and proton therapy. Selected clinical data on second cancer induction among radiotherapy patients are also covered. Problems in past studies and controversial issues are discussed. The needs for future studies are presented at the end.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,783
Recommendations of the International Commission on Radiological Protection
(1961) · Postgraduate Medical Journal · doi:10.1136/pgmj.37.425.168-b · Cited by 5,862
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,314
Cancer Epidemiology and Prevention
(2006) · doi:10.1093/acprof:oso/9780195149616.001.0001 · Cited by 3,369
Health Risks from Exposure to Low Levels of Ionizing Radiation:: BEIR VII Phase 2
Earth, D. O. (2006) · CERN Document Server (European Organization for Nuclear Research) · Cited by 2,190
Preface, Executive Summary and Glossary
(2007) · Annals of the ICRP · doi:10.1016/j.icrp.2007.10.003 · Cited by 2,106
Prescribing, recording, and reporting photon beam therapy
Icru (1993) · Medical Entomology and Zoology · Cited by 1,996
Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know
Brenner, D. J., Doll, R., Goodhead, D. T., Hall, E. J., Land, C. E., Little, J. B., Lubin, J. H., Preston, D. L., Preston, R. J., Puskin, J. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235592100 · Cited by 1,765
Recommendations of the International Commission on Radiological Protection
(1959) · Health Physics · doi:10.1097/00004032-195901000-00001 · Cited by 1,703
Radiation-induced second cancers: the impact of 3D-CRT and IMRT
Hall, E. J., & Wuu, C.-S. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)00073-7 · Cited by 1,301
Cited by
Heavy-ion tumor therapy: Physical and radiobiological benefits
Schardt, D., Elsässer, T., & Schulz-Ertner, D. (2010) · Reviews of Modern Physics · doi:10.1103/revmodphys.82.383 · Cited by 778
Newhauser, W. D., & Zhang, R. (2015) · Physics in Medicine and Biology · doi:10.1088/0031-9155/60/8/r155 · Cited by 675
Assessing the risk of second malignancies after modern radiotherapy
Newhauser, W. D., & Durante, M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3069 · Cited by 380
Nuclear physics in particle therapy: a review
Durante, M., & Paganetti, H. (2016) · Reports on Progress in Physics · doi:10.1088/0034-4885/79/9/096702 · Cited by 345
Self-citationKry, S. F., Bednarz, B., Howell, R. M., Dauer, L., Followill, D., Klein, E., Paganetti, H., Wang, B., Wuu, C., & George Xu, X. (2017) · Medical Physics · doi:10.1002/mp.12462 · Cited by 307
Self-citationTubiana, M. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.12.016 · Cited by 280
Radiotheranostics in oncology: Making precision medicine possible
Aboagye, E. O., Barwick, T. D., & Haberkorn, U. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21768 · Cited by 131
“, 2‐Gy fractions daily over weeks in EBRT (to achieve tumor target dose of up to 100 Gy [although the organs‐at‐risk dose of about 5–50 Gy limits the ideal target tumor dose]).(81) This perhaps propels DNA repair to the fore as a key radioresistance mechanism.”
Background
Metadata
- Authors
- Xu, X. G., Bednarz, B., & Paganetti, H.
- Venue
- Physics in Medicine and Biology
- Publisher
- IOP Publishing
- Published
- 2008-06-09
- Volume
- 53
- Issue
- 13
- Pages
- R193-R241
- ISSN
- 0031-9155 (ISSN-L)
- 1361-6560
- OpenAlex
- W2099156085
- Cited by
- 415
- References
- 136
- FWCI
- 29.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.